MYC and angiosarcoma: Our findings align with previous observations in angiosarcomas, where tumors exhibiting greater immune activity—i.e., a ‘hot’ microenvironment—particularly those lacking MYC amplification or located in the head and neck region, were associated with more favorable outcomes [10,12,16,17,19,20,27,28].